We found a highly significant antagonism between SARS-CoV-2 infection and COVID-19 severity with the systemic response to abatacept.
← all excerpts
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19.
1
—
—